EDQM snubs Efpia over anti-counterfeiting system
This article was originally published in SRA
Executive Summary
The European Department for the Quality of Medicines (EDQM) has rejected an invitation from the European pharmaceutical industry federation Efpia to take part in a tender for the implementation of Efpia's anti-counterfeiting system, saying that a system run by "industry and business stakeholders" cannot adequately serve the interests of patients1.